AOX1
AOX1 (aldehyde oxidase 1, also known as AO or AOH1) is a cytoplasmic flavoprotein of the xanthine dehydrogenase family. It oxidises a broad range of aldehydes and azaheterocyclic compounds and contributes to the metabolism of drugs and other xenobiotics. Browse Assay Genie's current range of AOX1 research reagents below, or read on for the biology behind the target.
AOX1 primarily catalyses oxidation reactions on a wide range of drug and xenobiotic substrates, taking part in their oxidative biotransformation. It acts on at least three structural types of substrate: aldehydes such as benzaldehyde, retinal, pyridoxal and vanillin; aromatic azaheterocyclic compounds such as phthalazine, quinazoline and phenanthridine; and quaternary azaheterocyclic compounds such as 1-methylnicotinamide and nicotine imine. Aldehydes are converted to carboxylic acids, while aromatic and quaternary azaheterocycles are converted to lactams. These reactions typically use molecular oxygen as the terminal electron acceptor and generate hydrogen peroxide as a by-product.
Under some conditions, particularly with electron-deficient substrates or limited oxygen, aldehyde oxidase can also catalyse reductions, using N-methylnicotinamide, 2-hydroxypyrimidine or benzaldehyde as the electron donor. These reductive activities include N-O bond reductions in nitro groups (for example imidacloprid), hydroxamic acids and oxazoles (for example zonisamide), as well as N-S bond reduction of sulfoxides such as sulindac. NCBI also notes that the enzyme can, under certain conditions, catalyse the formation of superoxide.
The AOX1 gene encodes a protein that belongs to the xanthine dehydrogenase family and is classed by HGNC among the flavoproteins. The enzyme is assigned EC 1.2.3.1 and is found in the cytoplasm. Mouse and rat both carry an Aox1 ortholog. RefSeq describes aldehyde oxidase as a candidate gene for amyotrophic lateral sclerosis, which makes the AOX1 protein of interest beyond pharmacology.
AOX1 oxidises many drug and xenobiotic substrates, so it is relevant to understanding oxidative biotransformation of small-molecule compounds.
The enzyme converts aldehydes and azaheterocycles to carboxylic acids and lactams, and can reduce nitro groups, oxazoles and sulfoxides under some conditions.
Aldehyde oxidase generates hydrogen peroxide and, under certain conditions, superoxide, linking its activity to reactive oxygen species production.
AOX1 is described by RefSeq as a candidate gene for amyotrophic lateral sclerosis, prompting study of its role in disease.
AOX1 is a cytoplasmic enzyme that oxidises aldehydes, aromatic azaheterocycles and quaternary azaheterocycles, mainly as part of drug and xenobiotic metabolism. It typically uses molecular oxygen and produces hydrogen peroxide. Under some conditions it can also carry out reduction reactions.
The HGNC name is aldehyde oxidase 1, and UniProt lists the protein as aldehyde oxidase. Aliases include AO and AOH1. The enzyme is classified as EC 1.2.3.1 and belongs to the xanthine dehydrogenase/aldehyde oxidase family of flavoproteins.
Mouse and rat each have an Aox1 ortholog. NCBI Gene (RefSeq) describes aldehyde oxidase as a candidate gene for amyotrophic lateral sclerosis. Check the datasheet of any product for its validated reactivity.
Other molybdenum-containing flavoenzymes, xenobiotic-metabolising enzymes and oxidative stress markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q06278; product specifications from Assay Genie datasheets.